Carisbamate vs placebo
Drowsiness/somnolence (Event rate during treatment, length of treatment varied across trials) · people with drug‐resistant focal epilepsy
Carisbamate may leads to higher adverse events: somnolence compared with placebo (low certainty).
1 finding from 1 review
- RR 1.82 [1.28, 2.58]4 studies · 2211 participantsLow